Publication of positive Phase 1 study results for EB-101 gene therapy clinical trial for epidermolysis bullosa

Abeona Therapeutics Inc. a clinical-stage biopharmaceutical company focused on delivering gene therapies for life-threatening rare diseases, announced that positive clinical trial results from the...